Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis

被引:41
|
作者
Chanda, Diptiman [1 ]
Kurundkar, Ashish [1 ]
Rangarajan, Sunad [1 ]
Locy, Morgan [1 ]
Bernard, Karen [1 ]
Sharma, Nirmal S. [1 ]
Logsdon, Naomi J. [1 ]
Liu, Hui [1 ]
Crossman, David K. [2 ]
Horowitz, Jeffrey C. [3 ]
De Langhe, Stijn [4 ]
Thannickal, Victor J. [1 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Genet, Heflin Ctr Genom Sci, Birmingham, AL 35294 USA
[3] Univ Michigan, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[4] Natl Jewish Hlth, Div Cell Biol, Dept Pediat, Denver, CO 80206 USA
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
FIBROBLAST GROWTH FACTOR-10; STEM-CELLS; TGF-BETA; BRANCHING MORPHOGENESIS; SONIC HEDGEHOG; TRANSCRIPTION FACTORS; LUNG DEVELOPMENT; GENE-EXPRESSION; FGF10; MECHANISMS;
D O I
10.1038/srep37445
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cellular plasticity and de-differentiation are hallmarks of tissue/organ regenerative capacity in diverse species. Despite a more restricted capacity for regeneration, humans with age-related chronic diseases, such as cancer and fibrosis, show evidence of a recapitulation of developmental gene programs. We have previously identified a resident population of mesenchymal stromal cells (MSCs) in the terminal airways-alveoli by bronchoalveolar lavage (BAL) of human adult lungs. In this study, we characterized MSCs from BAL of patients with stable and progressive idiopathic pulmonary fibrosis (IPF), defined as <5% and >= 10% decline, respectively, in forced vital capacity over the preceding 6-month period. Gene expression profiles of MSCs from IPF subjects with progressive disease were enriched for genes regulating lung development. Most notably, genes regulating early tissue patterning and branching morphogenesis were differentially regulated. Network interactive modeling of a set of these genes indicated central roles for TGF-beta and SHH signaling. Importantly, fibroblast growth factor-10 (FGF-10) was markedly suppressed in IPF subjects with progressive disease, and both TGF-beta 1 and SHH signaling were identified as critical mediators of this effect in MSCs. These findings support the concept of developmental gene re-activation in IPF, and FGF-10 deficiency as a potentially critical factor in disease progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis
    Diptiman Chanda
    Ashish Kurundkar
    Sunad Rangarajan
    Morgan Locy
    Karen Bernard
    Nirmal S. Sharma
    Naomi J. Logsdon
    Hui Liu
    David K. Crossman
    Jeffrey C. Horowitz
    Stijn De Langhe
    Victor J. Thannickal
    [J]. Scientific Reports, 6
  • [2] Developmental Reprogramming In Progressive Idiopathic Pulmonary Fibrosis
    Chanda, D.
    Kurundkar, A.
    Rangarajan, S.
    Locy, M. L.
    Bernard, K.
    Sharma, N. S.
    Logsdon, N. J.
    Liu, H.
    Crossman, D. K.
    Horowitz, J. C.
    Thannickal, V. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [3] Multipotent Mesenchymal Stromal Cells for Pulmonary Fibrosis?
    Purdon, Stefanie
    Patete, Carissa L.
    Glassberg, Marilyn K.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 357 (05): : 390 - 393
  • [4] Mesenchymal stem cells in idiopathic pulmonary fibrosis
    Li, Xiaohong
    Yue, Shaojie
    Luo, Ziqiang
    [J]. ONCOTARGET, 2017, 8 (60) : 102600 - 102616
  • [5] Safety of IV Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis
    Limper, Andrew H.
    [J]. CHEST, 2017, 151 (05) : 951 - 952
  • [6] Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
    Tzouvelekis, Argyrios
    Toonkel, Rebecca
    Karampitsakos, Theodoros
    Medapalli, Kantha
    Ninou, Ioanna
    Aidinis, Vasilis
    Bouros, Demosthenes
    Glassberg, Marilyn K.
    [J]. FRONTIERS IN MEDICINE, 2018, 5
  • [7] Immune Reprogramming in Human Subjects after Extracorporeal Mesenchymal Stromal Cell Therapy
    Barcia, R.
    Nguyen, S.
    O'Rourke, B.
    Igo, P.
    Tilles, A.
    Miller, B.
    Parekkadan, B.
    [J]. CYTOTHERAPY, 2020, 22 (05) : S11 - S11
  • [8] Basal cells of the human airways acquire mesenchymal traits in idiopathic pulmonary fibrosis and in culture
    Jonsdottir, Hulda R.
    Arason, Ari J.
    Palsson, Ragnar
    Franzdottir, Sigridur R.
    Gudbjartsson, Tomas
    Isaksson, Helgi J.
    Gudmundsson, Gunnar
    Gudjonsson, Thorarinn
    Magnusson, Magnus K.
    [J]. LABORATORY INVESTIGATION, 2015, 95 (12) : 1418 - 1428
  • [9] Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis
    Yang, Shengnan
    Liu, Peipei
    Jiang, Yale
    Wang, Zai
    Dai, Huaping
    Wang, Chen
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [10] Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial
    Campo, Arantza
    Maria Gonzalez-Ruiz, Jose
    Andreu, Enrique
    Alcaide, Ana B.
    Ocon, Maria M.
    De-Torres, Juan
    Pueyo, Jesus
    Cordovilla, Rosa
    Villaron, Eva
    Sanchez-Guijo, Fermin
    Barrueco, Miguel
    Nunez-Cordoba, Jorge
    Prosper, Felipe
    Zulueta, Javier J.
    [J]. ERJ OPEN RESEARCH, 2021, 7 (02)